Coffin-Siris syndrome with café-au-lait spots, obesity and hyperinsulinism caused by a mutation in the <i>ARID1B</i> gene

  • Sonmez Fatma Mujgan
    Department of Child Neurology, Turgut Özal University Faculty of Medicine
  • Uctepe Eyyup
    Department of Medical Genetics, Health Sciences University, Diskapi Yildirim Beyazit Training and Research Hospital
  • Gunduz Mehmet
    Department of Medical Genetics, Turgut Özal University Faculty of Medicine Department of Otolaryngology, Turgut Özal University Faculty of Medicine
  • Gormez Zeliha
    Advanced Genomics and Bioinformatics Research Center, The Scientific and Technological Research Council of Turkey (TUBITAK-BILGEM)
  • Erpolat Seval
    Department of Dermatology, Turgut Özal University Faculty of Medicine
  • Oznur Murat
    Department of Medical Genetics, Turgut Özal University Faculty of Medicine
  • Sagiroglu Mahmut Samil
    Advanced Genomics and Bioinformatics Research Center, The Scientific and Technological Research Council of Turkey (TUBITAK-BILGEM)
  • Demirci Huseyin
    Advanced Genomics and Bioinformatics Research Center, The Scientific and Technological Research Council of Turkey (TUBITAK-BILGEM)
  • Gunduz Esra
    Advanced Genomics and Bioinformatics Research Center, The Scientific and Technological Research Council of Turkey (TUBITAK-BILGEM)

抄録

<p>Coffin-Siris syndrome (CSS) (MIM 135900) is characterized by developmental delay, severe speech impairment, distinctive facial features, hypertrichosis, aplasia or hypoplasia of the distal phalanx or nail of the fifth digit and agenesis of the corpus callosum. Recently, it was shown that mutations in the ARID1B gene are the main cause of CSS, accounting for 76% of identified mutations. Here, we report a 15 year-old female patient who was admitted to our clinic with seizures, speech problems, dysmorphic features, bilaterally big, large thumb, café-au-lait (CAL) spots, obesity and hyperinsulinism. First, the patient was thought to have an association of neurofibromatosis and Rubinstein Taybi syndrome. Because of the large size of the NF1 gene for neurofibromatosis and CREBBP gene for Rubinstein Taybi syndrome, whole exome sequence analysis (WES) was conducted and a novel ARID1B mutation was identified. The proband WES test identified a novel heterozygous frameshift mutation c.3394_3395insTA in exon 13 of ARID1B (NM_017519.2) predicting a premature stop codon p.(Tyr1132Leufs*67). Sanger sequencing confirmed the heterozygous c.3394_3395insTA mutation in the proband and that it was not present in her parents indicating de novo mutation. Further investigation and new cases will help to understand this phenomenon better.</p>

収録刊行物

  • Intractable & Rare Diseases Research

    Intractable & Rare Diseases Research 5 (3), 222-226, 2016

    特定非営利活動法人 バイオ&ソーシャル・サイエンス推進国際研究交流会

被引用文献 (1)*注記

もっと見る

参考文献 (15)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ